{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:51:09Z","timestamp":1790945469278,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.exphem.2010.10.001","type":"journal-article","created":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T15:00:34Z","timestamp":1286809234000},"page":"66-76.e2","source":"Crossref","is-referenced-by-count":30,"title":["Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL\u2013positive CML cells"],"prefix":"10.1016","volume":"39","author":[{"given":"Ute","family":"Brassat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Balabanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Dierlamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Braig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Sirma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagatay","family":"G\u00fcnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Wege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Fehse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Gontarewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Dikomey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Borgmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim H.","family":"Br\u00fcmmendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2010.10.001_bib1","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products","volume":"247","author":"Lugo","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.exphem.2010.10.001_bib2","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1073\/pnas.85.18.6622","article-title":"A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes","volume":"85","author":"Moyzis","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2010.10.001_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(03)12384-7","article-title":"Association between telomere length in blood and mortality in people aged 60 years or older","volume":"361","author":"Cawthon","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2010.10.001_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0921-8734(91)90018-7","article-title":"Telomere loss: mitotic clock or genetic time bomb?","volume":"256","author":"Harley","year":"1991","journal-title":"Mutat Res"},{"key":"10.1016\/j.exphem.2010.10.001_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0092-8674(01)00492-5","article-title":"Switching and signaling at the telomere","volume":"106","author":"Blackburn","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2010.10.001_bib6","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/sj.leu.2404339","article-title":"Telomere length dynamics in normal hematopoiesis and in disease states characterized by increased stem cell turnover","volume":"20","author":"Brummendorf","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2010.10.001_bib7","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood.V95.6.1883","article-title":"Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry","volume":"95","author":"Brummendorf","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.10.001_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood-2005-07-2815","article-title":"BCR\/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance","volume":"108","author":"Koptyra","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.10.001_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0968-0004(02)02110-2","article-title":"Oxidative stress shortens telomeres","volume":"27","author":"von Zglinicki","year":"2002","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.exphem.2010.10.001_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1749-6632.2003.tb03229.x","article-title":"Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemia","volume":"996","author":"Brummendorf","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.exphem.2010.10.001_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Melo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2010.10.001_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood.V96.1.358","article-title":"Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase","volume":"96","author":"Boultwood","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.10.001_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.leu.2400560","article-title":"Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression","volume":"11","author":"Ohyashiki","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2010.10.001_bib14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0042-6822(73)90341-3","article-title":"A new technique for the assay of infectivity of human adenovirus 5 DNA","volume":"52","author":"Graham","year":"1973","journal-title":"Virology"},{"key":"10.1016\/j.exphem.2010.10.001_bib15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/mt.2008.6","article-title":"A multicolor panel of novel lentiviral \u2018gene ontology\u2019 (LeGO) vectors for functional gene analysis","volume":"16","author":"Weber","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.exphem.2010.10.001_bib16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature03841","article-title":"Oncogene-induced senescence as an initial barrier in lymphoma development","volume":"436","author":"Braig","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2010.10.001_bib17","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1593\/neo.09664","article-title":"Aurora kinase inhibitor PHA-739358 suppresses growth of hepatocellular carcinoma in vitro and in a xenograft mouse model","volume":"11","author":"Benten","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.exphem.2010.10.001_bib18","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1182\/blood-2007-09-113175","article-title":"Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I","volume":"111","author":"Gontarewicz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.10.001_bib19","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/nprot.2006.263","article-title":"Flow cytometry and FISH to measure the average length of telomeres (flow FISH)","volume":"1","author":"Baerlocher","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.exphem.2010.10.001_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.190.2.157","article-title":"Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood","volume":"190","author":"Rufer","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2010.10.001_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.radonc.2008.07.028","article-title":"Impact of homologous recombination on individual cellular radiosensitivity","volume":"90","author":"Koch","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.exphem.2010.10.001_bib22","first-page":"839","article-title":"p53 in chronic myeloid leukemia cell lines","volume":"6","author":"Bi","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2010.10.001_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0092-8674(00)80762-X","article-title":"p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis","volume":"97","author":"Chin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2010.10.001_bib24","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1093\/emboj\/20.24.6958","article-title":"A highly selective telomerase inhibitor limiting human cancer cell proliferation","volume":"20","author":"Damm","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2010.10.001_bib25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10637-007-9063-6","article-title":"Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors","volume":"25","author":"Mueller","year":"2007","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.exphem.2010.10.001_bib26","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/07357900802072905","article-title":"Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines","volume":"26","author":"Parsch","year":"2008","journal-title":"Cancer Invest"},{"key":"10.1016\/j.exphem.2010.10.001_bib27","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/13495","article-title":"Inhibition of telomerase limits the growth of human cancer cells","volume":"5","author":"Hahn","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2010.10.001_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrc2393","article-title":"Telomere dysfunction and tumour suppression: the senescence connection","volume":"8","author":"Deng","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2010.10.001_bib29","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1038\/sj.onc.1207564","article-title":"Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy","volume":"23","author":"Preto","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2010.10.001_bib30","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1038\/sj.onc.1206054","article-title":"Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant","volume":"21","author":"Delhommeau","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2010.10.001_bib31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0022-5347(05)66045-4","article-title":"Inhibition of telomerase is related to the life span and tumorigenicity of human prostate cancer cells","volume":"166","author":"Guo","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.exphem.2010.10.001_bib32","doi-asserted-by":"crossref","first-page":"14276","DOI":"10.1073\/pnas.96.25.14276","article-title":"Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death","volume":"96","author":"Herbert","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2010.10.001_bib33","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/sj.leu.2403177","article-title":"Telomerase is limiting the growth of acute myeloid leukemia cells","volume":"17","author":"R\u00f6th","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2010.10.001_bib34","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1182\/blood-2004-03-0852","article-title":"Tumor cells escape suicide gene therapy by genetic and epigenetic instability","volume":"104","author":"Frank","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.10.001_bib35","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","article-title":"The biology of CML blast crisis","volume":"103","author":"Calabretta","year":"2004","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X10004959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X10004959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T19:21:35Z","timestamp":1591989695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X10004959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0301472X10004959"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2010.10.001","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}